Increased Serum Adipsin Correlates with MAFLD and Metabolic Risk Abnormalities.

Jie PanQiuyan LiYan SunYingying GuYijie DingNengzhi PangYujia ZhouLei PeiMengqi GaoSixi MaYing XiaoFeilong WuDe HuYu-Ming ChenLili Yang

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2023)

Increased serum adipsin correlates with MAFLD. Both adipsin levels as well as fatty liver severity increase with higher numbers of metabolic risk abnormalities.

Keyphrases